Study guide

Symptom Management Neutropenia Pain and Nutrition Case Lab

OCN Oncology Certified Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: OCN Exam Orientation and Official Source Control

Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness

2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care

Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures

3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment

Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation

4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards

Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development

5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy

Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation

6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents

Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation

7 Chapter 7: Symptom Management and Supportive Care

Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination

8 Chapter 8: Oncologic Emergencies and Rapid Escalation

Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage

9 Chapter 9: Psychosocial Dimensions of Oncology Care

Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals

10 Chapter 10: Mixed OCN Case Labs

New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab

11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness

Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning

Symptom Management Neutropenia Pain and Nutrition Case Lab

Key Takeaways Explain This Topic AI

Neutropenic fever = single oral temp >=38.3 C (101 F) or >=38.0 C (100.4 F) sustained over 1 hour with ANC <500; it is an emergency requiring cultures and IV antibiotics within 1 hour.

Avoid rectal temperatures, suppositories, and enemas in neutropenia; teach hand hygiene, neutropenic food safety, and prompt fever reporting.

Cancer pain uses an around-the-clock long-acting opioid plus breakthrough dosing; new back pain with weakness or bowel/bladder change is cord compression, not routine pain.

Start a stimulant laxative bowel regimen (senna +/- docusate) with every scheduled opioid; fiber and bulk laxatives alone are insufficient for opioid-induced constipation.

Unintentional weight loss >=5% in a month or >=10% over six months meets malnutrition criteria and warrants dietitian referral and provider notification.

Last updated: June 2026

  • Case Lab: Neutropenia, Pain, and Nutrition
  • Case Snapshot

A 59-year-old on dose-dense chemotherapy calls at 7 PM with temperature 38.4 C , chills, sore throat, and fatigue. The same patient has metastatic bone pain rated 8/10 despite short-acting opioids and has lost 8% of body weight in two months because food tastes metallic. One case crosses infection risk, pain, nutrition, medication safety, and education.

Neutropenic Fever

Febrile neutropenia is defined (IDSA) as a single oral temperature >=38.3 C (101 F) or >=38.0 C (100.4 F) sustained over one hour , with an absolute neutrophil count (ANC) <500 cells/mm3 (or expected to fall below 500 within 48 hours). It is an oncologic emergency because the inflammatory response is blunted and infection progresses rapidly. The standard of care is to draw blood cultures (peripheral and each lumen of any central line) and start broad-spectrum IV antibiotics, such as an antipseudomonal beta-lactam (cefepime, piperacillin-tazobactam, or a carbapenem), within one hour of presentation.

This 38.4 C patient meets the fever threshold after myelosuppressive therapy and must be told to come in now, not to take acetaminophen and call in the morning. Acetaminophen masks fever and delays recognition. Assess temperature method, timing, chills, localizing symptoms, last chemotherapy date, central line, prophylaxis, allergies, and safe transport, then direct immediate evaluation per protocol and notify the provider.

Symptom Nursing Concern Priority Action

Fever or rigors after chemotherapy Neutropenic infection/sepsis Immediate evaluation; cultures + IV antibiotics within 1 hour

  • Sore throat, cough, dysuria, line redness Local infection source Include in handoff and assessment
  • Hypotension, confusion, dyspnea Sepsis/instability Emergency response
  • Took antipyretic before calling Masked fever Document dose/time, continue urgent triage

Teach before neutropenia: monitor temperature, when to call, avoid rectal temperatures/suppositories/enemas, hand hygiene, neutropenic food safety (no raw/undercooked foods, washed produce, no unpasteurized items), central-line care, vaccination timing with oncology, and avoiding crowds and sick contacts. Absence of fever does not make severe symptoms safe.

Cancer Pain

Pain assessment is functional and cause-oriented: location, intensity, quality, onset, aggravating/relieving factors, effect on sleep and function, neurologic symptoms, bowel function, sedation, falls, current regimen, last dose, adherence barriers, and patient goals. New back pain with weakness, numbness, or bowel/bladder change is not routine pain and may signal spinal cord compression requiring emergency escalation.

For persistent 8/10 metastatic bone pain, notify the provider for regimen review; effective cancer pain control typically pairs an around-the-clock long-acting opioid with a short-acting breakthrough dose of roughly 10-20% of the 24-hour total. RN interventions include medication reconciliation, teaching scheduled versus PRN dosing, safe storage, no sharing, sedation/driving precautions, and nonpharmacologic strategies (positioning, heat/cold when appropriate, relaxation, PT referral).

Always pair scheduled opioids with a stimulant laxative bowel regimen (senna, with or without docusate) ; bulk/fiber laxatives alone are inadequate and can worsen opioid-induced constipation. The nurse does not independently increase opioid doses beyond orders.

Nutrition Support

Cancer cachexia and treatment effects (mucositis, nausea, diarrhea, early satiety, taste change, dysphagia, depression, financial barriers) erode intake. Trend matters more than a single complaint: unintentional loss >=5% in one month or >=10% over six months meets malnutrition criteria. This patient's 8% two-month loss warrants dietitian referral and provider notification. For metallic taste, teach plastic utensils, cold or room-temperature foods, tart flavors if mucosa is intact, oral care before meals, small frequent high-protein meals, and oral nutrition supplements.

Escalate mucositis, dysphagia, aspiration, uncontrolled nausea, severe diarrhea, or dehydration. Do not blame the patient for not eating; assess barriers and match the intervention to the cause. Document fever details, chemotherapy timing, urgent-evaluation handoff, pain assessment, medication-safety teaching, nutrition risk, referrals, and timed follow-up, and confirm the febrile patient actually reached evaluation.

Numbers, Equianalgesia, and Common Traps

The symptom-management domain rewards exact thresholds. ANC is calculated as total white blood cell count multiplied by the percentage of segmented neutrophils plus bands; an ANC under 500 (or under 100 for profound neutropenia) defines the highest infection risk. Nadir, the lowest count, typically occurs 7-14 days after most chemotherapy, which is when fever calls are most dangerous. Filgrastim (G-CSF) supports neutrophil recovery but is given per order, not as a nurse-initiated fever treatment.

Pain and nutrition anchors:

Breakthrough opioid dosing is roughly 10-20% of the total 24-hour dose , offered for pain that breaks through scheduled long-acting therapy.

Opioids have no ceiling dose , but sedation preceding respiratory depression is the key safety sign; naloxone is reserved for true respiratory depression, not routine drowsiness.

Cancer-related pain is best managed with scheduled dosing for constant pain; PRN-only regimens for constant pain are a common wrong answer.

Malnutrition criteria: loss of >=5% in one month or >=10% in six months of usual body weight.

Classic traps: telling a febrile post-chemo patient to take acetaminophen and wait (masks fever, delays cultures and antibiotics), recommending bulk fiber alone for opioid-induced constipation (inadequate; needs a stimulant laxative), and treating new back pain with weakness as routine bone pain (it is possible cord compression). On mixed symptom items, treat fever as an emergency, pain as multidimensional and functional, and nutrition as a measurable trend, then confirm teaching with reassessment and caregiver instructions.